IntroductIon
H igh-throughput screening (hts) allows one to quickly conduct potentially millions of biochemical or genetic tests. screening results represent a starting point for drug design or lead to the identification of tool compounds with which to explore a biological process. 1 to expand the information acquired from an hts experiment, different assay formats have been developed to capture multiple biological readouts from a single sample, for example, assays that simultaneously quantify the production of multiple cytokines 2 or assay systems that concurrently detect multiple gene transcripts. 3 other multiplexed methods developed for hts include monitoring of the concentration of intracellular proteins using time-resolved fluorescence resonance energy transfer as well as cell viability following compound exposure. 4 Moreover, the availability of methods for monitoring the quality of such multiparametric assay formats now allows the rational optimization of such experiments. 5 to study transcriptional activity, the most commonly used reporter gene systems are based on luciferase enzymes. these assays have been widely accepted for multiple applications, including hts, because of their sensitivity and large dynamic range. in drug discovery, high-throughput quantification of luciferase expression is commonly used for compound screening, as several thousand samples per hour can be tested. Moreover, luciferase-based experiments can be multiplexed to allow the detection of different luciferases within the same cell. the dual reporter assays are commonly used to increase the precision and the accuracy of an experiment by simultaneously monitoring the reporter results, correlated with the effect of specific experimental conditions, with an internal control that serves as the baseline response and minimizes sample variability. the most common dual reporter genes are renilla and firefly luciferase, which use different substrates (colenterazine and luciferin, respectively), allowing the sequential monitoring of both luciferases from a single sample. 6 the dual reporter system based on the vectors encoding "red and green" click beetle (Pyrophorus plagiophthalamus) luciferases provides a method to generate red and green dual-color luminescence from a single sample upon a single reagent addition, as both enzymes use the luciferin as a substrate. 7 Both signals can be measured independently but simultaneously, as the maximum emission wavelengths for the red and green luciferases are distinct, helping to reduce assay variability. several commercially available detection systems have been developed for the in vitro detection of luciferase activity but are designed with a final step involving cell lysis to maximize the luminescence signal. the use of a luciferin solution permits multiparameter assay development and helps to decrease assay artifacts.
As previously shown by King et al., 8 the direct addition of luciferin to cultured cells expressing the firefly, and in this report the click beetle, luciferases allows reporter gene expression to be monitored. this report also shows that it is possible to multiplex this luminescence readout with an orthogonal measure of cell viability. By combining these simple extensions to standard luciferase reporter gene assays, it is possible to detect compound artifacts that inhibit the luciferase or cell viability as well as true actives affecting the specific target.
MAterIALS And MethodS

Cell culture
All of the cell culture reagents were provided by invitrogen unless stated. the MDA-MB-231-Bcl2 cell line (novation pharmaceuticals, Burnaby, canada) was cultured in DMeM medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamax, 2 mM glucose, 100 µg/mL hygromycin, 50 u/mL penicillin, and 50 µg/mL streptomycin. Wild-type huh7 and huh7-luc (provided by K. Lin, niBr) were cultured in DMeM medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamax, 2 mM glucose, 50 µg/mL geneticin (only for huh7-luc), 50 u/mL penicillin, and 50 µg/mL streptomycin. heK293 cells (invitrogen, carlsbad, cA) were cultured in DMeM medium supplemented as mentioned by the manufacturer. All cells were incubated in a 100% humidified atmosphere of 5% co 2 at 37 °c.
Compound treatment
cells were seeded 5 hours (h) before treatment as described in the results section in 30 µL of medium in white 384-well microplates (BD 354661) or 5 µL of medium in white 1536-well microplates (greiner Bio-one 789183-A) with the Multidrop dispenser (thermo scientific, Waltham, MA). compounds, dissolved in 90% DMso, were added to cells using the echo 550 liquid transfer station (Labcyte inc., sunnyvale, cA) as described in the results section. cells were incubated with compounds for up to 24 h. cycloheximide (sigma c104450) and benzalkonium chloride (sigma B6295) powders were diluted in 90% DMso and added in the culture medium at the required final concentration.
Monitoring firefly luciferase activity
Luciferin assays. the 10 mM D-luciferin stock solution was prepared by dissolving the D-luciferin powder (sigma L6152) in 100% DMso and stored at -20 °c. For each experiment, fresh aliquots of the D-luciferin stock solution were diluted in complete medium to the desired concentration. cells were incubated with luciferin for up to 24 h.
Steady-Glo assays. Firefly luciferase monitoring was performed using the steady-glo assay system (promega e2550; promega, Madison, Wi) following the manufacturer's instructions.
in all experiments, the luminescence was measured using the Wallac ViewLux microplate imager (perkinelmer 1430-0010; perkinelmer, Waltham, MA).
Cell viability assays
A stock solution of 1 mg/mL (3.981mM) resazurin was prepared in 100% DMso. For each experiment, fresh dilutions of 0.1 mg/mL resazurin were prepared in tris-hcl 5 mM (ph 5.5). cells were incubated with resazurin at a concentration of between 1 µM and 500 µM, for 10 min to 3 h. resofurin fluorescence was measured on the envision Multilabel reader (perkinelmer) using 560-nm excitation and 590-nm emission wavelengths.
Screening assay procedure
the luciferase screening assay was run using 2818 compounds from a proprietary library of natural products. this experiment was performed in a 1536-well format in duplicate: one plate was used to monitor the compound effect in a kinetic experiment using luciferin solution, and one plate was used to monitor the compound effect using steady-glo reagent (promega e2550). Briefly, cells were seeded in the assay plates at a density of 7500 cells/well and incubated overnight. plates without or with 100 µM luciferin solution were incubated with 10 µM compound, and for the plate containing D-luciferin, the luminescence was monitored at regular times over 26 h. After 24 h, toxicity was monitored using the resazurin reduction assay described above. the final luminescence time point measured using the luciferin solution or the steady-glo reagent was then performed.
Screening data analysis
Assay quality was defined by calculation of the Z′ factor 9 with two controls: DMso as the neutral compound and benzalkonium chloride as the active compound that kills the cells.
screening results were analyzed using an in-house developed software, and data were compared with origin and spotfire softwares.
the luminescence reading for each sample was corrected using the neutral and active controls as 0% and -100% residual activity, consistent with internal novartis data reporting conventions. As there are currently no known compounds modulating the reporter gene assay in the desired manner, potential hits were considered active by the following, purely arbitrary, criteria: samples showing activity less than -50% residual activity (for inhibitors) or greater than 50% residual activity (for activators) with a compound toxicity remaining between -25% and 25% activity.
reSuLtS And dIScuSSIon
Detection of firefly luciferase expression with luciferin
First, the impact on the luminescence signal of parameters such as luciferin concentration, incubation time, and cell number were monitored using an huh7-luc cell line expressing firefly luciferase expressed from the cMV promoter driving a bicistronic transcript, with luciferase under the control of the eMcV ires 5′utr mrnA ( fig. 1A) .
to characterize the influence of the luciferin concentration on luminescence, huh7-luc cells seeded in 1536-well plates were incubated with 0 to 600 µM luciferin for 24 h ( fig. 1B) . the results showed that the luminescence increases with increasing luciferin concentration and reaches a plateau. Despite in vitro studies showing that high concentrations of luciferin inhibit firefly luciferase (due to accumulation of inhibitory oxyluciferin), inhibition of luciferase was not observed in these conditions. it was decided to use either 50 µM or 100 µM of luciferin in the following experiments to monitor changes in luciferase activity and to avoid the saturation of the reader by high signal. to evaluate luciferin stability, huh7 wild-type cells, not expressing the luciferase enzyme (so as to avoid specific luciferin consumption), were seeded in 1536-well plates and incubated with 0 to 1.2 mM luciferin. After 24 h incubation, half of the medium was transferred to huh7-luc cells cultured under the same conditions. After 5 min incubation, the luminescence signal was similar to the one observed when huh7-luc cells were incubated for 24 h with luciferin ( fig. 1B) . this result suggests that the luciferin is stable for at least 24 h at 37 °c with cells in culture medium. Moreover, the regular monitoring of the luminescence during 24 h showed that in the presence of 50 µM luciferin, it was possible to detect luciferase activity within 5 min. there was also a twofold increase of the signal over 24 h, a value consistent with the growth rate of these cells ( fig. 1c) .
next, the luminescence signal intensity was monitored as a function of the cell number (2000, 4000, 8000, 12 000 huh7 cells/ well in a 1536-well plate) after a 2-h incubation. the luminescence increased with cell number in a linear manner (R 2 > 0.9) for each luciferin concentration and is proportional to the number of cells ( fig. 1d) .
Additional experiments monitoring the click beetle red or green luciferases, transiently expressed in heK293 for 48 h with either 50 µM luciferin or with the chroma-glo reagent, showed similar signal-to-background ratios (supplementary data). the signal generated by the chroma-glo reagent is 30 to 40 times higher than the signal obtained using just luciferin, possibly due to the cell lysis caused by the chroma-glo.
these experiments confirm that direct addition of luciferin to culture medium allows luciferase expression to be monitored in an automation-compatible manner. this method does not require cell lysis and yet still meets the requirements needed for a specific reporter gene assay (i.e., signal proportional to substrate concentration, incubation time, and cell number).
Multiplex assay format with resazurin
recently, multiplexed detection of luciferase activity using glo reagents with a noninvasive measure of cell viability using resazurin has been reported. 10 this simple, rapid, and sensitive method is based on the reduction of resazurin, a blue nonfluorescent dye, to resofurin, a quantifiable pink, fluorescent dye, within viable cells. 11 the influence of luciferin luminescence and resofurin fluorescence on each other was tested using MDA-MB-231-Bcl2 cells, expressing the firefly reporter gene fused to the 3′utr of the Bcl2 mrnA ( fig. 2A) . First, the influence of monitoring cell viability using the resofurin-fluorescence on oxyluciferin-luminescence was evaluated. concentrations of between 0 and 500 µM resazurin were added 1 h before the addition of 50 µM luciferin, and luminescence was monitored after various incubation times ( fig. 2B) . the luminescence signal decreased with increasing resazurin concentration. in the presence of 2 µM resazurin, a concentration routinely used in our lab, the luminescence signal is decreased by approximately 10% to 15%, which is still compatible with monitoring of luciferase activity. so as resofurin fluorescence interferes with the luminescence signal, optimization of the resazurin concentration with a given luciferin concentration will be required during assay development.
next, an experiment examining the effect of luciferin on the resazurin cell viability assay was conducted ( fig. 2c) . After a 24-h incubation, in the presence of increasing concentrations of luciferin, resazurin was added, and the plates were incubated for a further 2 h at 37 °c. in the presence of luciferin, the resofurin fluorescence was decreased by about 10%, which again is still compatible with monitoring cell viability.
Further experiments following the viability of heK293 cells transfected with plasmids encoding click beetle red and/or green luciferases showed that the resofurin signal was decreased by about 15% when luminescence was also detected using luciferin (supplementary data). thus, the click beetle luciferase expression is still compatible with resofurin monitoring of cell viability. in summary, it is possible to optimize the assay system to allow multiplex monitoring of both resofurin assessment of cell viability and luciferin detection of reporter gene expression.
Firefly luciferase detection during a screening process
the confirmation that luciferin could be used to follow luciferase activity in an hts-compatible format enables the evaluation of its use under realistic screening conditions. thus, a screen using this assay format process was performed in two parallel duplicate screens of 2818 compounds ( fig. 3) . MDA-MB-231-Bcl2 cells were incubated with 10 µM compound (0.5% DMso), and the luciferase expression was monitored at regular time points throughout the experiment using 50 µM luciferin or at the endpoint experiment using the steady-glo reagent. the plot of results at the 26-h time point using both the luciferin and steady-glo detection methods showed a correlation coefficient R 2 = 0.63, with compounds showing the highest activity being identified in both formats ( fig. 3A) . compounds showing greater than 50% activity inhibition or activation, as well as less than 50% toxicity, gave a hit rate of 3.8%. More active compounds were identified when using steady-glo than using luciferin; this could be due to the lysis step induced by the glo reagent resulting in a higher luminescence signal and so creating an assay with a larger dynamic range. thus, the use of the luciferin solution-based assay may avoid the identification of compounds that have only a small effect on the reporter gene expression but that are detectable by the steady-glo assay format.
real-time monitoring of the luciferase activity during the experiment using luciferin enabled the selection of three types of compounds with different effects on the luminescence signal over time ( fig. 3B gives three examples of such compounds). the results demonstrated the identification of nonactive as well as activator or inhibitor compounds. this assay format also allows the speed of action and the efficiency of the compounds fIG. 3. primary screening assay using luciferin solution and steadyglo approaches. huh7-luc cells, expressing the firefly luciferase reporter gene under the control of the eMcV ires 5′utr mrnA seeded in 1536-assay plate. cells were treated with 10 µM compound coming from a proprietary library of natural products (2818 small molecules). two plates were simultaneously incubated with 100 µM luciferin solution, and luminescence was monitored during the 26 h following luciferin solution addition. two plates were tested using the steady-glo reagent after 26 h of incubation with the compounds. (A) scatter plot of the luminescence using the luciferin solution (x axis) or the steady-glo reagent (y axis). pearson correlation coefficient R 2 = 0.63. (B) real-time compound effect monitoring. graph representing the luminescence of three selected compounds, nonactive ( . . ▲ . . ), inhibitor (--•--), and activator ( ■ ) monitored over the experiment. each point represents the value from one assay well. For each compound, the table on the left gives the toxicity of each compound evaluated using the resazurin assay and compared with the data obtained using the controls DMso and benzalkonium chloride.
to be monitored over time. After 26 h incubation, the steadyglo reagent confirmed the results found with the luciferin solution for the three example compounds (data not shown). the resazurin assay, performed in the same plate to monitor the cell viability after 24 h of incubation of the compounds, allowed the toxicity of these compounds to be included in the defined thresholds ( fig. 3B, table) . this confirmed that cell viability using the resazurin could be combined with monitoring reporter gene activity using the luciferin substrate, in a real-world screening situation. similar results were obtained from a screen of ˜2 5 000 compounds that monitored a luciferase reporter gene using either 50 µM luciferin or a Bright-glo endpoint assay after 24 h of compound incubation (supplementary data). When comparing the two readings obtained from the two 24-h time points, the vast majority of compounds gave comparable signals, suggesting that the two readout approaches are essentially equivalent. however, a prominent subpopulation of compounds gave very low activity using the luciferin approach and presented a relatively wide range of activity using the Brightglo. When the compounds with a normalized signal of 50% or less at the 10-min time point using luciferin were removed from the analysis, the majority of this subpopulation disappeared. this suggests that the activity of these compounds is due to direct inhibition of the luciferase signal, and so this approach is useful for identifying such compounds. the results obtained using either a commercial reagent assay kit or the luciferin solution showed acceptable results for a cell-based screen, with the most active compounds being found in both assay formats. however, if the reporter gene expression is too low (i.e., due to the presence of a weak promoter or if low cell number are required for the screen), the luciferin assay format could be insufficient to allow detection of the luminescence signal. in such cases, monitoring luciferase expression would be more accurate by using the commercial endpoint reagents.
Real-time monitoring of compound effects on luciferase activity
the MDA-MB-231-Bcl2 cells were then used to monitor, in real-time, compound effects on the reporter gene over a period of 24 h. inactive, unspecific, and specific compounds used in this assay were identified in a previous screen using a commercially available luciferase assay system (steady-glo, promega). the specific compound had been shown to cause a decrease of the luciferase activity associated with the decrease of both reporter gene and endogenous Bcl-2 mrnAs and proteins levels (data not shown).
cells were simultaneously incubated with a dilution series ranging from 0 to 10 µM of compound and 50 µM luciferin, and luminescence was measured regularly during 24 h of incubation. in the presence of the inactive compound, there is little influence on the luminescence signal at each time point and for each compound concentration (compound A; fig. 4A ). the inactive compound does not alter the luciferase expression, confirming that direct addition of luciferin enables its exclusion during a screening experiment. to identify false-positive compounds that might appear active due to nonspecific inhibition of luciferase activity, either by the luciferase inhibition or the signal quenching, the luminescence was measured on cells incubated with a compound previously shown to induce a decrease of the signal when added 20 min after the steady-glo (compound B; data not shown; fig. 4B ). A decrease of the luminescence signal, observed after just 5 min of incubation in the presence of low compound concentrations (0.05 µM), confirmed the identification of this compound as a false-positive compound during a screen using luciferin and time-course monitoring.
next, the effect of inhibiting global protein synthesis using cycloheximide, an antibiotic blocking remove protein translation, was evaluated. After incubation times of between 10 and 60 min, luminescence stayed stable ( fig. 4c) . At 3 h of incubation, the luminescence decreased with the increase of the cycloheximide concentration, showing the specific inhibition of reporter gene synthesis.
experiments were then performed with a compound previously shown to destabilize the firefly-Bcl2 mrnA (compound D; data not shown). When the compound and the luciferin were added together, it was possible to follow the effect of the compound over time. the luminescence was inhibited after only 5 min at the highest concentration tested (10 µM) and decreased after 24 h incubation at much lower concentrations (ic 50 ≈ 0.5 µM; fig. 4d ). this suggests that although the compound may display quenching activity at the highest concentration, at lower concentrations it has a specific effect on luciferase expression. in summary, these results show that the real-time monitoring of the reporter gene expression enables one to follow the kinetics of compound action, providing a tool to compare the speed of activity and efficiency of each compound. this allows hit selection based on potency and kinetics of action.
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